KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Interest Expenses (2018 - 2025)

Historic Interest Expenses for Elanco Animal Health (ELAN) over the last 8 years, with Q3 2025 value amounting to $52.0 million.

  • Elanco Animal Health's Interest Expenses fell 1034.48% to $52.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $186.0 million, marking a year-over-year decrease of 2734.38%. This contributed to the annual value of $235.0 million for FY2024, which is 1516.25% down from last year.
  • Elanco Animal Health's Interest Expenses amounted to $52.0 million in Q3 2025, which was down 1034.48% from $48.0 million recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's Interest Expenses ranged from a high of $74.0 million in Q2 2023 and a low of $40.0 million during Q1 2025
  • For the 5-year period, Elanco Animal Health's Interest Expenses averaged around $59.4 million, with its median value being $60.0 million (2021).
  • As far as peak fluctuations go, Elanco Animal Health's Interest Expenses surged by 28125.0% in 2021, and later plummeted by 3939.39% in 2025.
  • Elanco Animal Health's Interest Expenses (Quarter) stood at $55.0 million in 2021, then grew by 12.73% to $62.0 million in 2022, then increased by 8.06% to $67.0 million in 2023, then crashed by 31.34% to $46.0 million in 2024, then grew by 13.04% to $52.0 million in 2025.
  • Its Interest Expenses stands at $52.0 million for Q3 2025, versus $48.0 million for Q2 2025 and $40.0 million for Q1 2025.